Ventyx Biosciences Inc

General ticker "VTYX" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $175.0M

Ventyx Biosciences Inc does not follow the US Stock Market performance with the rate: -9.7%.

Estimated limits based on current volatility of 3.6%: low 2.18$, high 2.34$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.88$, 7.26$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.39$, 4.60$]

Financial Metrics affecting the VTYX estimates:

  • Negative: Non-GAAP EPS, $ of -3.30 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -56.20 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
  • Negative: -1.03 < Inventory ratio change, % of 0

Similar symbols

Short-term VTYX quotes

Long-term VTYX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $67.15MM $113.14MM $207.99MM
Operating Income $-67.15MM $-113.14MM $-207.99MM
Non-Operating Income $-16.60MM $4.71MM $15.03MM
Interest Expense $0.10MM $0.00MM $0.00MM
R&D Expense $58.48MM $87.74MM $175.77MM
Income(Loss) $-83.75MM $-108.43MM $-192.96MM
Profit(Loss) $-83.75MM $-108.43MM $-192.96MM
Stockholders Equity $279.20MM $353.89MM $243.92MM
Assets $291.48MM $371.40MM $277.69MM
Operating Cash Flow $-38.65MM $-98.77MM $-166.52MM
Capital expenditure $0.26MM $0.28MM $0.51MM
Investing Cash Flow $-214.37MM $-74.93MM $100.94MM
Financing Cash Flow $323.55MM $167.77MM $53.33MM
Earnings Per Share* $-1.55 $-2.06 $-3.30

* EPS are Split Adjusted, recent splits may be reflected with a delay.